Therapeutic effect of hyperoxygenated solution on acute lung injury induced by oleic acid

European Surgical Research

Volumn 41, Issue 1, 2008, Pages 37-43

  Xu, R F ^a   Li, T T ^b   Feng, X Y ^b   Zhang, H ^a   Song, B ^a   Liu, C R ^a   Xu, L X ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury, rabbits; Hyperoxygenated solution; Myeloperoxidase; Oleic acid; Tumor necrosis factor

Indexed keywords

HYPEROXYGENATED SOLUTION; MYELOPEROXIDASE; OLEIC ACID; OXYGEN; OXYGEN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG ALVEOLUS; LUNG EDEMA; LUNG FLUID; LUNG LAVAGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; RANDOMIZATION; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; WATER CONTENT;

ANIMALS; ANOXIA; FEMALE; INFUSIONS, INTRAVENOUS; LUNG; MALE; OLEIC ACID; OXYGEN; OZONE; RABBITS; RESPIRATORY DISTRESS SYNDROME, ADULT; SODIUM CHLORIDE;

EID: 46749119451     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127731     Document Type: Article

References (35)

1. Griffith BP, Carroll RG, Hardesty RL, Peel RL, Borovetz HS: Selected lobar injury after infusion of oleic acid. J Appl Physiol 1979;47:706-711.
2. Schuster DP: ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 1994;149:245-260.
3. Metz C, Sibbald WJ: Anti-inflammatory therapy for acute lung injury. A review of animal and clinical studies. Chest 1991;100:1110-1119.
4. Bachofen M, Weibel ER: Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982;3:35-56.
5. Sun YH, Zhang PZ, Hu XH, Chen Z, Cheng AY, Zhong SH: A new method of oxygen delivery to preventing and relieving the anoxia injury - an experimental study and clinical application of hyperoxygen compound sodium chloride solution in treatment of burn shock. Natl Med J China (Zhonghua Yi Xue Za Zhi) 2004;84:18.
6. Gao C, Xu L, Chai W, Sun X, Zhang H, Zhang G: Amelioration of intestinal ischemia-reperfusion injury with intraluminal hyperoxygenated solution: studies on structural and functional changes of enterocyte mitochondria. J Surg Res 2005;129:298-305.
7. Jia CY, Chen B, Wang YM, Zang YM: The effect of hyperoxic solution on acute myocardial hypoxia in scalded rabbits. Chin J Burns (Zhonghua Shao Shang Za Zhi) 2000;16:272.
8. Gao C, Chai W, Xu L, Zhang G, Zhang H, Han L, Sun X: Protective Effects of Hyperoxygenated Solution Preconditioning on Intestinal Ischemia-Reperfusion Injury in Rabbits. J Surg Res 2006.
9. Zeng Z, Xu LX, Li R: Protective effect of hyperoxia solution on brain injury resulting from ischemia and reperfusion in rabbits. Di-si Junyi Daxue Xuebao (J Fourth Mil Med Univ) 2002;23:1363-1365.
10. Sun XD, Cai W, Ma JH: Influence of hyperoxic liquid on biochemical indexes and ultrastructure during myocardial ischemia reperfusion. Di-si Junyi Daxue Xuebao (J Fourth Mil Med Univ) 2001;22:1176-1178.
11. Loehe F, Mueller C, Annecke T, Minor T, Bittmann I, Krombach F, Messmer K: Tissue damage of non-heart-beating donor lungs after long-term preservation: evaluation of histologic alteration, bronchoalveolar lavage, and energy metabolism. Shock 2002;17:502-507.
12. Müller C, Hoffmann H, Bittmann I, Isselhard W, Messmer K, Dienemann H, Schildberg FW: Hypothermic storage alone in lung preservation for transplantation: a metabolic, light microscopic and functional analysis after 18 hours of preservation. Transplantation 1997;63:625-630.
13. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM: The American - European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;157:1332-1347.
14. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brummer J, Rudolph V, Munzel T, Heitzer T, Meinertz T, Baldus S: Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA 2005;102:431-436.
15. Repine JE: Scientific perspectives on adult respiratory distress syndrome. Lancet 1992;339:466-469.
16. Mochizuki M, Ishii Y, Itoh K, Iizuka T, Morishima Y, Kimura T, Kiwamoto T, Matsuno Y, Hegab AE, Nomura A, Sakamoto T, Uchida K, Yamamoto M, Sekizawa K: Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am J Respir Crit Care Med 2005;171:1260-1266.
17. Chow CW, Herrera Abreu MT, Suzuki T, Downey GP: Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol 2003;29:427-431.
18. Wu JX, Xu MY, Zhang FJ, Zhu WZ: The effect of hydroxyethyl starch on capillary permeability in a rat model of acute lung injury. Zhonghua Ma Zui Xue Za Zhi (Chin J Anes) 2003;23:197-200.
19. Shah NS, Nakayama DK, Jacob TD, Nishio I, Imai T, Billiar TR, Exler R, Yousem SA, Motoyama EK, Peitzman AB: Efficacy of inhaled nitric oxide in oleic acid-induced acute lung injury. Crit Care Med 1997;25:153-158.
20. Schutte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996;9:1858-1867.
21. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995;108:1303-1314.
22. Tanaka N, Murata A, Uda K, Toda H, Kato T, Hayashida H, Matsuura N, Mori T: Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 1995;23:901-908.
23. Flitter WD: Free radicals and myocardial reperfusion injury. Br Med Bull 1993;49:545-555.
24. Xu LX, Wu LP, Zhang H, Ma JH, Zhang XF, Zeng Z: Basic pharmachological study of hyperoxygenic liquid on the treatment of hypoxic and hypoxemia disease. Zhongguo Yao li Xue Tong bao (Chin Phar Bull) 2002;18:560-562.
25. Johnston RA, Schwartzman IN, Flynt L, Shore SA: Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol 2005;288:L390-L397.
26. Ghio AJ, Turi JL, Madden MC, Dailey LA, Richards JD, Stonehuerner JG, Morgan DL, Singleton S, Garrick LM, Garrick MD: Lung injury after ozone exposure is iron dependent. Am J Physiol Lung Cell Mol Physiol 2007;292(suppl. 1):L134-L143.
27. Oyarzun M, Dussaubat N, Gonzalez S: Effect of 0.25 ppm ozone exposure on pulmonary damage induced by bleomycin. Biol Res 2005;38:353-358.
28. McGlennen RC: Human papillomavirus oncogenesis. Clin Lab Med 2000;20:383-406.
29. Calfee CS, Matthay MA: Nonventilatory treatments for acute lung injury and ARDS. Chest 2007;131:913-920.
30. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:884-892.
31. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
32. Slotman GJ, Burchard KW, D'Arezzo A, Gann DS: Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 1988;28:648-654.
33. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M: The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984;311:1137-1143.
34. The Acute Respiratory Distress Syndrome Network: Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002;30:1-6.
35. Ito K, Mizutani A, Kira S, Mori M, Iwasaka H, Noguchi T: Effect of Ulinastatin, a human urinary trypsin inhibitor, on the oleic acid-induced acute lung injury in rats via the inhibition of activated leukocytes. Injury 2005;36:387-394.